CWM
WST icon

CIBC World Markets’s West Pharmaceutical WST Stock Holding History

CIBC World Markets’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.75M Buy
+10,006
New +$2.74M 0.01% 547
2025
Q2 		$1.98M Buy
9,057
+321
+4% +$68.6K 0.01% 568
2025
Q1 		$1.96M Sell
8,736
-2,721
-24% -$750K 0.02% 508
2024
Q4 		$3.75M Buy
11,457
+1,570
+16% +$494K 0.02% 422
2024
Q3 		$2.97M Buy
9,887
+500
+5% +$153K 0.02% 440
2024
Q2 		$3.09M Buy
9,387
+1,960
+26% +$693K 0.02% 408
2024
Q1 		$2.94M Sell
7,427
-2,095
-22% -$775K 0.02% 416
2023
Q4 		$3.35M Buy
9,522
+5,445
+134% +$1.93M 0.02% 416
2023
Q3 		$1.53M Sell
4,077
-4,618
-53% -$1.79M 0.02% 408
2023
Q2 		$3.33M Buy
8,695
+4,951
+132% +$1.77M 0.03% 374
2023
Q1 		$1.3M Sell
3,744
-4,960
-57% -$1.45M 0.02% 445
2022
Q4 		$2.05M Buy
8,704
+7,580
+674% +$1.8M 0.01% 495
2022
Q3 		$277K Sell
1,124
-4,047
-78% -$1.23M ﹤0.01% 509
2022
Q2 		$1.56M Sell
5,171
-10,073
-66% -$3.28M 0.01% 449
2022
Q1 		$6.26M Buy
+15,244
New +$5.97M 0.05% 225
2021
Q4 		– Sell
-16,692
Closed -$7.09M – 654
2021
Q3 		$7.09M Buy
16,692
+11,566
+226% +$4.88M 0.05% 245
2021
Q2 		$1.84M Sell
5,126
-1,942
-27% -$642K 0.01% 444
2021
Q1 		$1.99M Sell
7,068
-6,554
-48% -$1.88M 0.01% 447
2020
Q4 		$3.86M Buy
13,622
+4,735
+53% +$1.33M 0.02% 412
2020
Q3 		$2.44M Buy
8,887
+1,677
+23% +$444K 0.02% 390
2020
Q2 		$1.64M Buy
+7,210
New +$1.42M 0.02% 436
2020
Q1 		– Sell
-39,000
Closed -$5.86M – 739
2019
Q4 		$5.86M Buy
+39,000
New +$5.68M 0.04% 364
2019
Q3 		– Sell
-18,800
Closed -$2.35M – 736
2019
Q2 		$2.35M Buy
+18,800
New +$2.22M 0.02% 552

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

CIBC World Markets's WST Position: Q4 2025 in Review

CIBC World Markets opened a new position in West Pharmaceutical (WST) in Q4 2025: 10,006 shares worth $2.75M. The stake represents 0.01% of the portfolio and ranks #547 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in WST as recently as Q2 2025.

CIBC World Markets first reported a position in WST in Q2 2019 and has held it in 23 quarters since. The position peaked at $7.09M in Q3 2021. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • CIBC World Markets held 10,006 shares of West Pharmaceutical worth $2.75M as of Q4 2025.
  • West Pharmaceutical was a new CIBC World Markets position in Q4 2025.
  • West Pharmaceutical made up 0.01% of CIBC World Markets's portfolio in Q4 2025, its #547 holding.
  • CIBC World Markets first reported a position in West Pharmaceutical in Q2 2019 and has held it in 23 quarters since.
  • CIBC World Markets's West Pharmaceutical position peaked at $7.09M in Q3 2021.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.